Medifast shares have fallen 7.6% since its second-quarter 2026 earnings report, underperforming the S&P 500. The company posted a narrower-than-expected loss of 28 cents per share, versus the consensus estimate of a 67-cent loss, while revenues declined 27.6% year over year to $76.4 million, slightly above expectations. Active earning coaches dropped 48.7% to approximately 11,700, but average revenue per coach rose 41% to $6,529, marking the third straight quarter of productivity gains. For the third quarter, Medifast expects revenues of $60-$80 million and a loss of 15-65 cents per share, and it reaffirmed its fiscal 2026 revenue outlook of $270-$300 million while narrowing its loss guidance to 25 cents to $1.75 per share. The company remains debt-free with $169.8 million in cash and investment securities as of June 2026.
MEDIFAST INCQ2 loss report and lowered guidance despite narrower-than-expected loss
The Chefs Warehouse Inc
Walmart Inc.
Amazon.com Inc